William Blair Downgrades Tenax Therapeutics to Market Perform

Benzinga Newsdesk www.benzinga.com Negative 92.9%

Neg 92.9% Neu 0% Pos 0%

William Blair analyst Matt Phipps downgrades Tenax Therapeutics (NASDAQ:TENX) from Outperform to Market Perform.

Comments

No comments yet. Be the first!